Globus Medical (GMED) Total Non-Current Liabilities (2011 - 2026)
Globus Medical's (GMED) quarterly Total Non-Current Liabilities came in at $686.7 million in Q1 2026, up 35.97% YoY from $505.0 million in Q1 2025, and down 3.04% on a QoQ basis from $708.2 million in Q4 2025.
Globus Medical (GMED) Total Non-Current Liabilities (2011 - 2026) Analysis & Trends
Globus Medical (GMED) has 16 years of Total Non-Current Liabilities data on file, last reported at $686.7 million in Q1 2026.
- Quarterly Total Non-Current Liabilities rose 35.97% year-over-year to $686.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $686.7 million (up 35.97% YoY) and the FY2025 annual result came in at $708.2 million, down 32.74% from the prior year.
- Total Non-Current Liabilities fell to $686.7 million in Q1 2026, from $708.2 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $1.1 billion in Q3 2023 to a low of $145.3 million in Q1 2022.
- A 5-year average of $607.9 million and a median of $671.7 million in 2025 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2024 — Total Non-Current Liabilities soared 512.3% — and 2025, when it slumped 44.5%.
- Tracing GMED's Total Non-Current Liabilities over 5 years: stood at $219.4 million in 2022, then surged by 384.73% to $1.1 billion in 2023, then dropped by 1.0% to $1.1 billion in 2024, then tumbled by 32.74% to $708.2 million in 2025, then dropped by 3.04% to $686.7 million in 2026.
- The last three Total Non-Current Liabilities figures came in at $686.7 million (Q1 2026), $708.2 million (Q4 2025), and $671.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Globus Medical | 11.59 Bn | 10.99 Bn | 548.17 Mn | 700.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 700.61 Mn |
| Mar 31, 2026 | 686.67 Mn |
| Dec 31, 2025 | 708.17 Mn |
| Sep 30, 2025 | 671.73 Mn |
| Jun 30, 2025 | 560.43 Mn |
| Mar 31, 2025 | 505.03 Mn |
| Dec 31, 2024 | 1.05 Bn |
| Sep 30, 2024 | 993.66 Mn |
| Jun 30, 2024 | 992.22 Mn |
| Mar 31, 2024 | 909.94 Mn |
| Dec 31, 2023 | 1.06 Bn |
| Sep 30, 2023 | 1.15 Bn |
| Jun 30, 2023 | 162.05 Mn |
| Mar 31, 2023 | 169.92 Mn |
| Dec 31, 2022 | 219.41 Mn |
| Sep 30, 2022 | 199.80 Mn |
| Jun 30, 2022 | 147.31 Mn |
| Mar 31, 2022 | 145.29 Mn |
| Dec 31, 2021 | 203.23 Mn |
| Sep 30, 2021 | 176.43 Mn |